Drug Trial Radar · NCT02279745
Long-term Safety and Efficacy of Ralinepag in Pulmonary Arterial Hypertension
Last checked: Nov 19, 2026Latest source record: Dec 22, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
45
Actual
Start
Jul 8, 2015
Primary completion
Mar 29, 2021
Study completion Mar 29, 2021
Sponsor
- Lead sponsor
- United TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Oct 31, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study was an open-label extension study to determine the long-term safety and tolerability of ralinepag in subjects with World Health Organization (WHO) Group 1 pulmonary arterial hypertension (PAH) who have completed Study APD811-003, or who were assigned to receive placebo and were discontinued due to clinical worsening.
Conditions
- Pulmonary Arterial Hypertension
Interventions
RalinepagDrug
Active
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Pulmonary Vascular ResistanceTime frame: At 1 or 2 years after the subject enrolled into the study, pending their last RHC prior to Protocol Amendment 2.
- Change From Baseline in Cardiac OutputTime frame: At 1 or 2 years after the subject enrolled into the study, pending their last RHC prior to Protocol Amendment 2.
- Change From Baseline in Cardiac IndexTime frame: At 1 or 2 years after the subject enrolled into the study, pending their last RHC prior to Protocol Amendment 2.
- Change From Baseline in Mean Pulmonary Arterial PressureTime frame: At 1 or 2 years after the subject enrolled into the study, pending their last RHC prior to Protocol Amendment 2.
Locations
46 sites in 10 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Cedars-Sinai Medical Center
Beverly Hills, California
David Geffen School of Medicine at UCLA
Los Angeles, California
University of California Davis Medical Center
Sacramento, California
Harbor-UCLA Medical Center
Torrance, California
University of Colorado Cardiac and Vascular Center, Anschutz Inpatient Pavilion
Aurora, Colorado
Cleveland Clinic Florida
Weston, Florida
University of Iowa Hospitals and Clinics
Iowa City, Iowa
Chest Medicine Associates
Portland, Maine
University of Maryland Medical Center
Baltimore, Maryland
Boston University Medical Center General Clinical Research Unit (GCRU)
Boston, Massachusetts
University of Michigan Health System
Ann Arbor, Michigan
UC Health
Cincinnati, Ohio
University Hospitals Case Medical Center
Cleveland, Ohio
The Ohio State University Wexner Medical Center - Martha Morehouse Medical Pavilion
Columbus, Ohio
UPMC, Presbyterian
Pittsburgh, Pennsylvania
UT Southwestern Medical Center
Dallas, Texas
Memorial Hermann Hospital - Texas Medical Center
Houston, Texas
Fiona Stanley Hospital
Murdoch, Australia
St. Vincent's Hospital
Darlinghurst, New South Wales, Australia
The Prince Charles Hospital
Chermside, Queensland, Australia
Royal Hobart Hospital
Hobart, Tasmania, Australia
St Vincent's Hospital
Fitzroy, Victoria, Australia
Multiprofile Hospital for Active Treatment "National Heart Hospital" EAD, Clinic of Cardiology
Sofia, Bulgaria
Multiprofile Hospital for Active Treatment " St. Anna", Sofia AD, Cardiology Clinic
Sofia, Bulgaria
Department of Internal Medicine I - Cardiology, University Hospital Olomouc
Olomouc, Czechia
Second Internal Clinic - Clinic of Cardiology and Angiology, 1st Faculty of Medicine, Charles University in Prague, General University Hospital in Prague
Prague, Czechia
Gottsegen Gyorgy Orszagos Kardiológiai lntézet - National Institute of Cardiology, Department of Adult Cardiology
Budapest, Hungary
Semmelweis University, Department of Pulmonology - Semmelweis Egyetem Pulmonológiai Klinika
Budapest, Hungary
University of Szeged Faculty of Medicine, 2nd Department of Medicine and Cardiology Center, Albert Szent-Györyi Clinical Center - SZTE ÁOK Szent-Györgyi A lbert Klinikai Központ I I. sz. Belgyógyászati Klini ka és Kard ilógiai Központ
Budapest, Hungary
University of Pecs, Medical School, Heart Institute - Pécsi Tudományegyetem, Klinikai Központ, Szívgyógyászati Klinika
Budapest, Hungary
University of Derecen Clinical Research Center Cardiology and Cardiac Surgery Department - Debreceni Egyetem Klinikai Kozpont Kardiologiai es Szivsebeszeti Klinika
Debrecen, Hungary
Medical University of Bialystok Clinical Hospital Cardiology Clinic - Uniwersytecki Szpital Kliniczny, Klinika Kardiologii z Oddziałem Intensywnego Nadzoru Kardiologicznego
Krakow, Poland
John Paul II Hospital in Cracov Department of Cardiac and Vascular Diseases - Krakowski Szpital Specjalistyczny im. Jana Pawła II, Oddział Kliniczny Chorób Serca i Naczyń
Krakow, Poland
Biegański Provincial Specialist Hospital Department of Cardiology - Wojewódzki Szpital Specjalistyczny im. dr Wł. Biegańskiego w Lodzi, Oddział Kardiologiczny
Lodz, Poland
"Prof. Dr. C.C. Iliescu" Institute of Cardiovascular Diseases, Department of Clinic Cardiology III - Institutul de Urgenţă pentru Boli Cardiovasculare "Prof. Dr. C.C. Iliescu", Secţia Clinica Cardiologie fIJ
Bucharest, Romania
"Marius Nasta" Institute of Pneumoftiziology, Department of Pneumoftiziology IV - Institutul de Pneumoftiziologie "Marius Nasta", Sectia Clinica Pneumoftiziologie IV
Bucharest, Romania
"Dr. Victor Babes" Clinic Hospital for Infesctious Diseases and Pneumoftiziology, Department of Clinic Pneumology II
Timișoara, Romania
Clinical Centre of Serbia (CCS), Cardiology Clinic - Klinicki Centar SrЬije, Klinika za kardiologiju
Belgrade, Serbia
Кlinicko-bolnicki Centar Zemun, Кlinika za internu medicinu, Sluzba za kardiologiju
Belgrade, Serbia
Showing 40 of 46 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.